Medically assisted reproduction and the desire of HIV-infected couples to have a child: Time for a change of attitude?;Assistance médicale à la procréation et désir d'enfant de couples infectés par le VIH: Le temps d'un changement d'attitude est-il venu?

Gynecologie Obstetrique et Fertilite

Volumn 29, Issue 5, 2001, Pages 339-348

  Englert, Y ^a   Van Vooren, J P ^a   Liesnard, C ^a   Laruelle, C ^a   Delbaere, A ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Artificial insemination; HIV infection; ICSI; Medically assisted procreation; Prevention; Reproduction semen; Sexual transmission; Vertical transmission

Indexed keywords

ARTIFICIAL INSEMINATION; CONCEPTION; DEVELOPED COUNTRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; REPRODUCTION; REVIEW; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION;

EID: 0034972316     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(01)00143-6     Document Type: Short Survey

References (102)

1. Couples sérodifférents: La demande auprès des centres biologiques d'assistance médicale à la procréation
2. Le sida: Indication d'insémination artificielle avec sperme de donneur anonyme?
3. Demandes d'IAD faites par des couples dont l'homme a des anticorps sériques anti-HIV
4. Insemination of HIV-negative women with processed semen of HIV-positive partners
5. Management offertile and infertile HIV positive patients wanting to become parents
6. Assisted reproduction for couples infected with the human immunodeficiency virus type 1
7. La femme VIH séropositive. État des lieux en France
8. Risk of HIV transmission from heterosexual adults with transfusion-associated infections
9. Sexual transmission of HIV
10. A cluster of HIV infection among heterosexual people without apparent risk factors
11. Sexual transmission of HIV: Infectiousness and prevention
12. Longitudinal study of human immunodeficiency virus transmission by heterosexual partners
13. Probability of female-to-male transmission of HIV-1 in Thaïland
14. Female to male transmission of human immunodeficiency virus type 1: Risk factors for seroconversion in men
15. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group
16. Heterosexual HIV-1 transmission and viral load in hemophilic patients
17. Risk for perinatal HIV-1 trandmission according to maternal immunologic, virologic, and placental factors
18. Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices
19. Attitudes towards the triple-therapies and safer sex: What a mix!
20. Association between culturable human immunodeficiency virus type 1 (HIV- 1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood
21. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission
22. HIV-1 in semen: An isolated virus reservoir
23. Detection and quantification of HIV-1 in semen: Identification of a subpopulation of men at high potential risk of viral sexual transmission
24. Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen
25. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract
26. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy
27. Working group on mother-to-child transmission of HIV Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: Results from 13 perinatal studies
28. Epidemiology of HIV infection in the newborn
29. Reduction of maternal-infant transmission of human immunodeficiency virus tyupe 1 with zidovudine treatnient
30. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
31. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
32. Reducing the risk of maternal-infant transmission of HIV by attacking the virus
33. Frequency of early in utero HIV-1 infection: A blind DNA polymerase chain reaction studyon 100 fetal thymuses
34. HIV transmission from breastfeeding - A study in Malawi
35. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
36. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomized trial
37. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
38. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial
39. ACOG opinion an scheduled cesarean delivery and the prevention of vertical transmission of HIV infection
40. The mode of delivery and the risk of vertical transmission of meta analyses of 15 prospective cohort studies human immunodeficiency virus type 1-a
41. Preventing perinatal transmission of human immunodeficiency virus in the United States
42. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1
43. Huge percentage of women volunteer for zidovudine project
44. Combination anti-retroviral therapy in human immunodeficiency virus-infected pregnant women
45. Mode of delivery and the risk of vertical transmission of HIV-1
46. Comment on abstracts from the litterature
47. Persistant mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
48. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
49. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
50. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor
51. HIV transmission through donor artificial insemination
52. HIV-1 infection by artificial insemination
53. Gamete Donation Guidelines. The Corsendonk consensus statements for the european union
54. Detection of human immunodeficiency virus DNA and RNA in semen by the Polymerase Chain Reaction
55. Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with acquired immune deficiency syndrome
56. White blood cells and HIV-1 in semen from vasectomized seropositive men
57. Sperm as vectors and cofactors for HIV-1 transmission
58. Spermatozoa as potential carriers of HIV
59. Detection of human immunodeficiency virus type 1 in semen from seropositive men using culture and polymerase chain reaction deoxyribonucleic acid amplification techniques
60. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen
61. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men
62. Recovery of human immunodeficiency virus type 1 from semen: Minimal impact of stage of infection and current antiviral chemotherapy
63. HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte
64. HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization
65. The case against an association between HIV-1 and sperm: Molecular evidence
66. Microscopic evidence against HIV-1 infection of germ cells or attachment to sperm
67. HTLV-III in cell cultived from semen of two patients with AIDS
68. Semen characteristics in HIV-1 positive men and the effect of semen washing
69. Which cell type in semen is the major source of HIV-DNA?
70. Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children
71. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors
72. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen
73. Quantification of HIV in semen: Correlation with antiviral treatment and immune status
74. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
75. AMP intra-conjugale: Quelle stratégìe de prise en charge? L'expérience italienne
76. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination
77. Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man
78. AMP intra-conjugale: Quelle stratégie de prise en charge? Expérience protocole NECO
79. C.D.C.: HIV infection and artificial insemination with processed semen
80. Reduced fertility associated with HIV: The contribution of pre-existing subfertility
81. Population-based study of fertility in women with HIV-1 infection in Uganda
82. The effect of HIV diagnosis on reproductive experience
83. Pregnancy and contraception in a French cohort of HIV-infected women
84. The impact of knowledge of human immunodeficiency virus serostatus on contraceptive choice and repeat pregnancy
85. Reproductive choice in individuals HIV-1 infected in south eastern Italy
86. Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers
87. Possible nosocomial transmission of HIV
88. Transmissions of hepatitis C virus during the ancillary procedures for assisted conception
89. Hepatitis B transmission from contaminated cryopreservation tank
90. Sperm cryopreservation: Is there a significant risk of cross-contamination?
91. Infections in IVF: Review and guidelines
92. Do physicians have an obligation to treat patients with AIDS?
93. Policy, ethics, and reproductive choice: Pregnancy and childbearing among HIV-infected women
94. The impact of human immunodeficiency virus serostatus on reproductive decisions of women
95. Reproductive decision-making and determinants of contraceptive use in HIV-infected women
96. Relations sexuelles, désir d'enfant et perception du temps
97. Safe sex and conception: A dilemna
98. Natural conceptions in HIV-negative women with HIV-infected partners
99. Unconventional conceptions and HIV
100. The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination
101. Human immunodeficiency virus infection, women, and pregnancy: Ethical issues in HIV disease in pregnancy